Details for Patent: 11,795,204
✉ Email this page to a colleague
Which drugs does patent 11,795,204 protect, and when does it expire?
Patent 11,795,204 protects ZEGALOGUE and ZEGALOGUE (AUTOINJECTOR) and is included in one NDA.
This patent has thirty-three patent family members in twenty-four countries.
Drugs Protected by US Patent 11,795,204
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zealand Pharma | ZEGALOGUE | dasiglucagon hydrochloride | SOLUTION;SUBCUTANEOUS | 214231-001 | Mar 22, 2021 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | METHOD OF TREATING DIABETIC HYPOGLYCEMIA | ⤷ Subscribe | ||||
| Zealand Pharma | ZEGALOGUE (AUTOINJECTOR) | dasiglucagon hydrochloride | SOLUTION;SUBCUTANEOUS | 214231-002 | Mar 22, 2021 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | METHOD OF TREATING DIABETIC HYPOGLYCEMIA | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,795,204
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 091866 | ⤷ Subscribe | |||
| Australia | 2013295035 | ⤷ Subscribe | |||
| Brazil | 112015001451 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
